According to the SmPCs, there is limited experience with semaglutide and liraglutide in severe renal impairment, with liraglutide not recommended in end-stage renal disease and semaglutide to be used with caution in severe impairment
Our Score: 4/5 We evaluate telehealth clinics based on the latest GLP-1 research, customer feedback, clinical transparency, and patient experience
Use these broad calculators for reconstitution, dose volume, and concentration checks before choosing a peptide-specific page
For example, participants in the trials reported side effects that were generally consistent with previous studies, such as gastrointestinal symptoms, which are one of the main reasons that can lead to discontinuation of the drugs
We make these results available
The doctor provides written attestation confirming your current weight and the date measured